Abstract
In a previous communication in this journal one of us (THJH) discussed evidence indicating that the simultaneous presence of an α-chain deficiency (α-thalassemia-2) and a heterozygosity for the β chain variant Hb S or Hb C results in a decreased production of the abnormal hemoglobin (1). It was shown that the level of Hb S in Hb S heterozygotes is decreased to less than 30% when an α-thalassemia-2 homozygosity (indicated by the -α/-α; βA/βS genic arrangement) is also present, that this level varies between 30 and 40% if an α-thalassemia-2 heterozygosity (the -α/αα; βA/βS genic arrangement) is present, and that the level is more than 40% but less than 50% if four α chain structural genes are active. Data from several studies (reviewed in 1, 2, and 3) have suggested some 2 to 5% Hb Bart's (or γ4) is present in the blood of Black newborn with a homozygosity for α-thalassemia-2 (irrespective of a β chain variant being present), less than 2% Hb Bart's in Black newborn with an α-thalassemia-2 heterozygosity, and no detectable amount of Hb Bart's in newborn with four active α chain genes.